| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Salidroside | Acute Lymphoblastic Leukemia | 1 | PM | 33968167 | 📋 | Salidroside overcomes dexamethasone resistance in T-acute lymphoblastic leukemia cells |
| Salidroside | Bladder Cancer | 1 | PM | 21520297 | 📋 | Rhodiola rosea extracts and salidroside decrease the growth of bladder cancer cell lines via inhibition of the mTOR pathway and induction of autophagy |
| Salidroside | Bone Cancer | 1 | PM | 31081055 | 📋 | Salidroside suppresses the growth and invasion of human osteosarcoma cell lines MG63 and U2OS in vitro by inhibiting the JAK2/STAT3 signaling pathway |
| Salidroside | Breast Cancer | 2 | PM | 37358272 | 📋 | Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration |
| Salidroside | Breast Cancer | 1 | PM | 34978808 | 📋 | Salidroside Promotes Sensitization to Doxorubicin in Human Cancer Cells by Affecting the PI3K/Akt/HIF Signal Pathway and Inhibiting the Expression of Tumor-Resistance-Related Proteins |
| Salidroside | Breast Cancer | 5 | PM | 33238796 | 📋 | Inhibitory effects of salidroside on MCF-7 breast cancer cells in vivo |
| Salidroside | Breast Cancer | 4 | PM | 25814002 | 📋 | Salidroside inhibits the growth of human breast cancer in vitro and in vivo |
| Salidroside | Breast Cancer | 3 | PM | 20541529 | 📋 | Salidroside induces cell-cycle arrest and apoptosis in human breast cancer cells |
| Salidroside | Cancer | 2 | PM | 34533789 | 📋 | Multiple mechanisms of salidroside on anti-tumor effects |
| Salidroside | Cancer | 1 | PM | 32144560 | 📋 | Advances in Research on Anticancer Properties of Salidroside |
| Salidroside | Cancer | 3 | PM | 20309622 | 📋 | A preliminary study: the anti-proliferation effect of salidroside on different human cancer cell lines |
| Salidroside | Chondrosarcoma | 1 | PM | 29035891 | 📋 | Inhibiting ROS-TFEB-Dependent Autophagy Enhances Salidroside-Induced Apoptosis in Human Chondrosarcoma Cells |
| Salidroside | Chronic Myeloid Leukemia | 2 | PM | 36369630 | 📋 | Mechanism of salidroside in the treatment of chronic myeloid leukemia based on the network pharmacology and molecular docking |
| Salidroside | Chronic Myeloid Leukemia | 1 | PM | 34539845 | 📋 | Salidroside inhibits chronic myeloid leukemia cell proliferation and induces apoptosis by regulating the miR-140-5p/wnt5a/β-catenin axis |
| Salidroside | Colon Cancer | 1 | PM | 25755753 | 📋 | Anticancer effect of salidroside on colon cancer through inhibiting JAK2/STAT3 signaling pathway |
| Salidroside | Colorectal Cancer | 2 | PM | 36465266 | 📋 | Effects of Salidroside Combined with Paclitaxel on Proliferation, Migration, and Epithelial Mesenchyme of Colorectal Cancer Cells |
| Salidroside | Colorectal Cancer | 1 | PM | 33749640 | 📋 | Salidroside induces cell apoptosis and inhibits the invasiveness of HT29 colorectal cells by regulating protein kinase R, NF-κB and STAT3 |
| Salidroside | Colorectal Cancer | 4 | PM | 29246220 | 📋 | Inhibition of autophagy enhances synergistic effects of Salidroside and anti-tumor agents against colorectal cancer |
| Salidroside | Colorectal Cancer | 5 | PM | 29115408 | 📋 | Salidroside could enhance the cytotoxic effect of L‑OHP on colorectal cancer cells |
| Salidroside | Colorectal Cancer | 3 | PM | 27748934 | 📋 | Salidroside induces apoptosis and autophagy in human colorectal cancer cells through inhibition of PI3K/Akt/mTOR pathway |
| Salidroside | Endometrial Cancer | 1 | PM | 37644107 | 📋 | Mechanism of salidroside in the treatment of endometrial cancer based on network pharmacology and molecular docking |
| Salidroside | Fibrosarcoma | 1 | PM | 35269801 | 📋 | Salidroside, 8( E)-Nuezhenide, and Ligustroside from Ligustrum japonicum Fructus Inhibit Expressions of MMP-2 and -9 in HT 1080 Fibrosarcoma |
| Salidroside | Fibrosarcoma | 2 | PM | 21978886 | 📋 | Salidroside inhibits migration and invasion of human fibrosarcoma HT1080 cells |
| Salidroside | Gastric Cancer | 5 | PM | 38436092 | 📋 | Salidroside inhibited the proliferation of gastric cancer cells through up-regulating tumor suppressor miR-1343-3p and down-regulating MAP3K6/MMP24 signal molecules |
| Salidroside | Gastric Cancer | 1 | PM | 34471002 | 📋 | Salidroside induces apoptosis in human gastric cancer cells via the downregulation of ENO1/PKM2/GLUT1 expression |
| Salidroside | Gastric Cancer | 3 | PM | 31918283 | 📋 | Salidroside induces apoptosis and protective autophagy in human gastric cancer AGS cells through the PI3K/Akt/mTOR pathway |
| Salidroside | Gastric Cancer | 2 | PM | 31432697 | 📋 | Anti-gastric cancer effect of Salidroside through elevating miR-99a expression |
| Salidroside | Glioma | 1 | PM | 24255575 | 📋 | Effects of salidroside on glioma formation and growth inhibition together with improvement of tumor microenvironment |
| Salidroside | Liver Cancer | 3 | PM | 37839277 | 📋 | Crosstalk between autophagy inhibitor and salidroside-induced apoptosis: A novel strategy for autophagy-based treatment of hepatocellular cancer |
| Salidroside | Liver Cancer | 2 | PM | 32439176 | 📋 | Salidroside induces apoptosis and triggers endoplasmic reticulum stress in human hepatocellular carcinoma |
| Salidroside | Liver Cancer | 1 | PM | 30942419 | 📋 | Salidroside suppresses the metastasis of hepatocellular carcinoma cells by inhibiting the activation of the Notch1 signaling pathway |
| Salidroside | Lung Cancer | 7 | PM | 37528345 | 📋 | Salidroside regulates tumor microenvironment of non-small cell lung cancer via Hsp70/Stub1/Foxp3 pathway in Tregs |
| Salidroside | Lung Cancer | 2 | PM | 37423604 | 📋 | Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624-mediated PD-L1 pathway |
| Salidroside | Lung Cancer | 1 | PM | 34457117 | 📋 | Salidroside Suppresses the Proliferation and Migration of Human Lung Cancer Cells through AMPK-Dependent NLRP3 Inflammasome Regulation |
| Salidroside | Lung Cancer | 3 | PM | 32992083 | 📋 | Systems pharmacology unravels the synergic target space and therapeutic potential of Rhodiola rosea L. for non-small cell lung cancer |
| Salidroside | Lung Cancer | 6 | PM | 32304408 | 📋 | Salidroside suppresses nonsmall cell lung cancer cells proliferation and migration via microRNA-103-3p/Mzb1 |
| Salidroside | Lung Cancer | 5 | PM | 31878993 | 📋 | [Salidroside induces anti-tumor effect in dendritic cells via ERK pathway] |
| Salidroside | Lung Cancer | 4 | PM | 30880481 | 📋 | Salidroside represses proliferation, migration and invasion of human lung cancer cells through AKT and MEK/ERK signal pathway |
| Salidroside | Melanoma | 1 | PM | 38588875 | 📋 | Salidroside induces mitochondrial dysfunction and ferroptosis to inhibit melanoma progression through reactive oxygen species production |
| Salidroside | Nasopharyngeal Cancer | 1 | PM | 35220889 | 📋 | Salidroside suppresses the activation of nasopharyngeal carcinoma cells via targeting miR-4262/GRP78 axis |
| Salidroside | Pancreatic Cancer | 2 | PM | 32758338 | 📋 | Salidroside inhibits proliferation, migration and invasion of human pancreatic cancer PANC1 and SW1990 cells through the AKT and ERK signaling pathway |
| Salidroside | Pancreatic Cancer | 1 | PM | 31162697 | 📋 | Salidroside ameliorated hypoxia-induced tumorigenesis of BxPC-3 cells via downregulating hypoxia-inducible factor (HIF)-1α and LOXL2 |
| Salidroside | Prostate Cancer | 1 | PM | 37545219 | 📋 | Salidroside suppresses proliferation and migration in prostate cancer via the PI3K/AKT pathway |
| Salidroside | Renal Cell Carcinoma | 1 | PM | 27314291 | 📋 | Salidroside reduces renal cell carcinoma proliferation by inhibiting JAK2/STAT3 signaling |
| Salidroside | Thyroid Cancer | 1 | PM | 31120636 | 📋 | Salidroside inhibits migration and invasion of poorly differentiated thyroid cancer cells |
